ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,586,552 | -23.4% | 240,857 | -0.9% | 0.01% | -16.7% |
| Q2 2023 | $11,206,269 | +272.5% | 242,928 | +223.8% | 0.01% | +200.0% |
| Q1 2023 | $3,008,783 | -21.0% | 75,032 | -10.9% | 0.00% | 0.0% |
| Q4 2022 | $3,807,275 | +24.7% | 84,220 | +11.9% | 0.00% | 0.0% |
| Q3 2022 | $3,052,637 | -41.2% | 75,235 | -12.7% | 0.00% | -50.0% |
| Q2 2022 | $5,190,880 | -13.2% | 86,190 | +2.9% | 0.00% | 0.0% |
| Q1 2022 | $5,981,960 | +47.7% | 83,794 | +135.6% | 0.00% | 0.0% |
| Q1 2021 | $4,050,000 | -21.4% | 35,571 | -4.4% | 0.00% | -20.0% |
| Q4 2020 | $5,150,000 | +89.1% | 37,202 | +12.3% | 0.01% | +66.7% |
| Q3 2020 | $2,723,000 | +9.6% | 33,131 | -1.8% | 0.00% | +50.0% |
| Q2 2020 | $2,484,000 | +61.2% | 33,725 | -2.8% | 0.00% | 0.0% |
| Q1 2020 | $1,541,000 | +9.7% | 34,687 | +5.5% | 0.00% | +100.0% |
| Q4 2019 | $1,405,000 | -2.4% | 32,889 | -2.8% | 0.00% | -50.0% |
| Q3 2019 | $1,439,000 | -32.9% | 33,852 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $2,143,000 | -9.4% | 33,748 | -1.1% | 0.00% | -33.3% |
| Q1 2019 | $2,366,000 | +87.2% | 34,122 | +17.3% | 0.00% | +50.0% |
| Q4 2018 | $1,264,000 | -45.6% | 29,078 | -4.4% | 0.00% | 0.0% |
| Q3 2018 | $2,322,000 | -12.9% | 30,422 | -12.3% | 0.00% | -33.3% |
| Q2 2018 | $2,666,000 | +57.3% | 34,691 | +4.3% | 0.00% | +50.0% |
| Q1 2018 | $1,695,000 | +20.0% | 33,247 | +9.2% | 0.00% | 0.0% |
| Q4 2017 | $1,412,000 | -12.6% | 30,439 | +0.3% | 0.00% | 0.0% |
| Q3 2017 | $1,616,000 | -15.7% | 30,334 | -1.7% | 0.00% | 0.0% |
| Q2 2017 | $1,917,000 | -1.3% | 30,864 | +7.7% | 0.00% | 0.0% |
| Q1 2017 | $1,943,000 | +12.4% | 28,652 | +16.6% | 0.00% | 0.0% |
| Q4 2016 | $1,729,000 | -0.7% | 24,582 | +0.1% | 0.00% | -33.3% |
| Q3 2016 | $1,742,000 | +45.5% | 24,552 | +0.3% | 0.00% | +50.0% |
| Q2 2016 | $1,197,000 | -63.8% | 24,482 | -57.6% | 0.00% | -33.3% |
| Q1 2016 | $3,308,000 | -48.4% | 57,742 | +1.0% | 0.00% | -50.0% |
| Q4 2015 | $6,415,000 | +17.0% | 57,185 | +0.4% | 0.01% | 0.0% |
| Q3 2015 | $5,484,000 | +137.4% | 56,938 | +152.3% | 0.01% | +100.0% |
| Q2 2015 | $2,310,000 | +569.6% | 22,568 | +306.5% | 0.00% | – |
| Q1 2015 | $345,000 | +54.7% | 5,552 | +9.2% | 0.00% | – |
| Q4 2014 | $223,000 | -26.4% | 5,085 | -5.2% | 0.00% | – |
| Q3 2014 | $303,000 | +57.8% | 5,364 | +25.5% | 0.00% | – |
| Q2 2014 | $192,000 | – | 4,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |